Applied Therapeutics Inc (NASDAQ: APLT) kicked off on Friday, down -45.92% from the previous trading day, before settling in for the closing price of $0.22. Over the past 52 weeks, APLT has traded in a range of $0.20-$1.50.
Annual sales at Healthcare sector company grew by 26.57% over the past five years. While this was happening, its average annual earnings per share was recorded 29.93%. With a float of $127.13 million, this company’s outstanding shares have now reached $144.30 million.
Applied Therapeutics Inc (APLT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Applied Therapeutics Inc is 11.90%, while institutional ownership is 65.69%. The most recent insider transaction that took place on Mar 04 ’25, was worth 4,561. In this transaction Chief Medical Officer of this company sold 10,366 shares at a rate of $0.44, taking the stock ownership to the 890,409 shares. Before that another transaction happened on Mar 04 ’25, when Company’s insider sold 14,502 for $0.44, making the entire transaction worth $6,381. This insider now owns 390,459 shares in total.
Applied Therapeutics Inc (APLT) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 0.33 earnings per share (EPS), higher than consensus estimate (set at -0.17) by 0.5. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 29.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.95% during the next five years compared to 26.57% growth over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Take a look at Applied Therapeutics Inc’s (APLT) current performance indicators. Last quarter, stock had a quick ratio of 0.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.10, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Applied Therapeutics Inc (NASDAQ: APLT) saw its 5-day average volume 14.25 million, a positive change from its year-to-date volume of 5.57 million. As of the previous 9 days, the stock’s Stochastic %D was 18.27%.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 0.53%, which indicates a significant decrease from 4.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0217 in the past 14 days, which was lower than the 0.0852 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7530, while its 200-day Moving Average is $0.5244. Nevertheless, the first resistance level for the watch stands at $0.1277 in the near term. At $0.1382, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.1470. If the price goes on to break the first support level at $0.1084, it is likely to go to the next support level at $0.0996. Assuming the price breaks the second support level, the third support level stands at $0.0891.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
The company with the Market Capitalisation of 16.93 million has total of 144,301K Shares Outstanding. Its annual sales at the moment are 460 K in contrast with the sum of -105,620 K annual income. Company’s last quarter sales were recorded 1,000 K and last quarter income was -18,990 K.
